ARCHIVES

FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available

This article is from The Cancer Letter archive.

Vol. 17 No. 45 | November 22, 1991

Download PDF Visit The Full Archive

Related Articles

Abstract Of Papers From ACTR Meeting

October 22, 1976

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

February 29, 2008

DeVita: No Decision Yet On FCRF Award

July 17, 1987

In Brief: Reagan Names David Korn New Chairman Of NCAB; Consensus Conference On Limb Sparing Planned

June 22, 1984

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987